Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML
Science Advances · 11.07.2025 · 11 (28)
DOI: 10.1126/sciadv.adw4871 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 11.07.2025. Verfasst von Gege Gui und 17 weiteren Autor:innen. Beteiligte Einrichtung: Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Immunotherapy, Single-Cell Analysis, Bone Marrow. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Given the graft-versus-leukemia effect observed with allogeneic hematopoietic stem cell transplantation in refractory or relapsed acute myeloid leukemia (AML), immunotherapies have been explored in nontransplant settings. We applied a multiomic approach to examine bone marrow interactions in patients with AML treated with pembrolizumab and decitabine. Using extensively trained nuclear and membrane segmentation models, we achieved precise transcript assignment and deep learning–based image analysis. To address read-depth limitations, we integrated single-cell RNA sequencing with single-cell spatial transcriptomics from the same sample. Quantifying cell-cell distances at the edge level enabled more accurate tumor microenvironment analysis, revealing global and local immune cell enrichment near leukemia cells postpembrolizumab treatment, potentially linked to clinical response. Furthermore, ligand-receptor analysis indicated potential alterations in specific signaling pathways between leukemia and immune cells following immunotherapy treatment. These findings provide insights into immune interactions in AML and may inform therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC, USA.
- Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
- Thoracic and GI Malignancies Branch, CCR, NCI, Bethesda, MD, USA.
- Laboratory of Myeloid Malignancies, Hematology Branch, NHLBI, Bethesda, MD, USA.
- Department of Laboratory Medicine, NIH Clinical Center, Bethesda, MD, USA.
- NanoString Technologies Inc., Seattle, WA, USA.
ORCID-Profile: Gege Gui, Molly A Bingham, Julius R Herzog, Abigail Wong-Rolle, Laura W Dillon, Meghali Goswami, Eddie Martin, Hermann F Degenhardt, Edward C Schrom, Christopher S Hourigan, Kasper D Hansen, Chen Zhao
Förderung
- NIGMS NIH HHS
Zitieren
APA
Gui, G., Bingham, M. A., Herzog, J. R., Wong-Rolle, A., Dillon, L. W., Goswami, M., Martin, E., Reeves, J., Kim, S., Bahrami, A., Degenhardt, H. F., Zaki, G., Divakar, P., Schrom, E. C., Calvo, K. R., Hourigan, C. S., Hansen, K. D., & Zhao, C. (2025). Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML. Science Advances, 11(28). https://doi.org/10.1126/sciadv.adw4871
Vancouver
Gui G, Bingham MA, Herzog JR, Wong-Rolle A, Dillon LW, Goswami M, et al. Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML. Science Advances. 2025;11(28). doi:10.1126/sciadv.adw4871
BibTeX
@article{Gui2025,
author = {Gui, Gege and Bingham, Molly A and Herzog, Julius R and Wong-Rolle, Abigail and Dillon, Laura W and Goswami, Meghali and Martin, Eddie and Reeves, Jason and Kim, Sean and Bahrami, Arya and Degenhardt, Hermann F and Zaki, George and Divakar, Prajan and Schrom, Edward C and Calvo, Katherine R and Hourigan, Christopher S and Hansen, Kasper D and Zhao, Chen},
title = {Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {28},
doi = {10.1126/sciadv.adw4871}
}
EUVIMED